Načítá se...
Prevalence of the CHEK2 R95* germline mutation
BACKGROUND: While germline CHEK2 mutations have been linked to a moderately elevated cancer risk, to date, a limited number of such mutations have been identified. Recently, we reported a germline nonsense mutation (C283T; R95*), introducing an early stop-codon, in two Norwegian patients diagnosed w...
Uloženo v:
| Vydáno v: | Hered Cancer Clin Pract |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5039915/ https://ncbi.nlm.nih.gov/pubmed/27708748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13053-016-0059-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|